New RNA flu shot shows promise in early safety trial
NCT ID NCT05227001
First seen Mar 10, 2026 · Last updated May 15, 2026 · Updated 11 times
Summary
This study tested a new type of flu vaccine called a self-amplifying RNA (saRNA) vaccine in 440 healthy adults aged 18 to 49. The goal was to see if it is safe and how the body responds compared to a licensed flu shot or a placebo. Participants received one injection and were followed for 6 months to monitor side effects and immune responses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA, HUMAN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Pharma CR, LLC
Miami, Florida, 33147, United States
-
Arizona Heart Rhythm Center
Phoenix, Arizona, 85016, United States
-
Benchmark Research
Austin, Texas, 78705, United States
-
CTI Clinical Research Center
Cincinnati, Ohio, 45212, United States
-
Coastal Carolina Research Center
North Charleston, South Carolina, 29405, United States
-
Comprehensive Cardiology Consultants
Pembroke Pines, Florida, 33028, United States
-
DM Clinical Research, Martin Diagnostic Clinic
Tomball, Texas, 77375, United States
-
Diablo Clinical Research, Inc.
Walnut Creek, California, 94598, United States
-
Eric S. Tiblier, MD
Austin, Texas, 78705, United States
-
Finlay Medical Research
Greenacres City, Florida, 33467, United States
-
Great Lakes Clinical Trials - Andersonville
Chicago, Illinois, 60640, United States
-
Hope Research Institute
Phoenix, Arizona, 85018, United States
-
Miami Clinical Research
Miami, Florida, 33155, United States
-
Mount Sinai Hospital
Miami Beach, Florida, 33140, United States
-
NYU Langone Health
New York, New York, 10016, United States
-
Panax Clinical Research
Miami Lakes, Florida, 33014, United States
-
Pines Care Research Center, LLC
Pembroke Pines, Florida, 33024, United States
-
Pinnacle Health Care Center
Pembroke Pines, Florida, 33024, United States
-
Pioneer Heart Institute
Lincoln, Nebraska, 68506, United States
-
SUNY Upstate Medical University
Syracuse, New York, 13215, United States
-
SUNY Upstate Medical University Global Health Laboratory
Syracuse, New York, 13210, United States
-
SUNY Upstate Medical University Institute for Global Health
Syracuse, New York, 13215, United States
-
The Pain Center of Arizona
Phoenix, Arizona, 85018, United States
-
Velocity Clinical Research, Omaha
Omaha, Nebraska, 68134, United States
Conditions
Explore the condition pages connected to this study.